132 related articles for article (PubMed ID: 19717303)
1. Pyrazole NNRTIs 3: optimisation of physicochemical properties.
Mowbray CE; Corbau R; Hawes M; Jones LH; Mills JE; Perros M; Selby MD; Stupple PA; Webster R; Wood A
Bioorg Med Chem Lett; 2009 Oct; 19(19):5603-6. PubMed ID: 19717303
[TBL] [Abstract][Full Text] [Related]
2. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
[TBL] [Abstract][Full Text] [Related]
3. Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate.
Mowbray CE; Burt C; Corbau R; Gayton S; Hawes M; Perros M; Tran I; Price DA; Quinton FJ; Selby MD; Stupple PA; Webster R; Wood A
Bioorg Med Chem Lett; 2009 Oct; 19(20):5857-60. PubMed ID: 19748778
[TBL] [Abstract][Full Text] [Related]
4. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
[TBL] [Abstract][Full Text] [Related]
5. Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motif.
Su DS; Lim JJ; Tinney E; Tucker TJ; Saggar S; Sisko JT; Wan BL; Young MB; Anderson KD; Rudd D; Munshi V; Bahnck C; Felock PJ; Lu M; Lai MT; Touch S; Moyer G; Distefano DJ; Flynn JA; Liang Y; Sanchez R; Perlow-Poehnelt R; Miller M; Vacca JP; Williams TM; Anthony NJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4328-32. PubMed ID: 20609585
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Liu N; Qin B; Sun LQ; Yu F; Lu L; Jiang S; Lee KH; Xie L
Bioorg Med Chem Lett; 2014 Aug; 24(16):3719-23. PubMed ID: 25042339
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.
Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA
J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
[TBL] [Abstract][Full Text] [Related]
10. Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
Tian Y; Du D; Rai D; Wang L; Liu H; Zhan P; De Clercq E; Pannecouque C; Liu X
Bioorg Med Chem; 2014 Apr; 22(7):2052-9. PubMed ID: 24631361
[TBL] [Abstract][Full Text] [Related]
11. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR
J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and molecular docking of pyrazolo [3,4d] thiazole hybrids as potential anti-HIV-1 NNRT inhibitors.
Kasralikar HM; Jadhavar SC; Goswami SV; Kaminwar NS; Bhusare SR
Bioorg Chem; 2019 May; 86():437-444. PubMed ID: 30771690
[TBL] [Abstract][Full Text] [Related]
13. N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Mitchell ML; Son JC; Lee IY; Lee CK; Kim HS; Guo H; Wang J; Hayes J; Wang M; Paul A; Lansdon EB; Chen JM; Eisenberg G; Geleziunas R; Xu L; Kim CU
Bioorg Med Chem Lett; 2010 Mar; 20(5):1585-8. PubMed ID: 20137928
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly.
Fader LD; Bethell R; Bonneau P; Bös M; Bousquet Y; Cordingley MG; Coulombe R; Deroy P; Faucher AM; Gagnon A; Goudreau N; Grand-Maître C; Guse I; Hucke O; Kawai SH; Lacoste JE; Landry S; Lemke CT; Malenfant E; Mason S; Morin S; O'Meara J; Simoneau B; Titolo S; Yoakim C
Bioorg Med Chem Lett; 2011 Jan; 21(1):398-404. PubMed ID: 21087861
[TBL] [Abstract][Full Text] [Related]
15. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.
Freeman GA; Andrews Iii CW; Hopkins AL; Lowell GS; Schaller LT; Cowan JR; Gonzales SS; Koszalka GW; Hazen RJ; Boone LR; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Reynolds DJ; Milton J; Ren J; Stuart DI; Stammers DK; Chan JH
J Med Chem; 2004 Nov; 47(24):5923-36. PubMed ID: 15537347
[TBL] [Abstract][Full Text] [Related]
16. FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Kim JT; Hamilton AD; Bailey CM; Domaoal RA; Wang L; Anderson KS; Jorgensen WL
J Am Chem Soc; 2006 Dec; 128(48):15372-3. PubMed ID: 17131993
[TBL] [Abstract][Full Text] [Related]
17. Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.
Li D; Zhan P; De Clercq E; Liu X
J Med Chem; 2012 Apr; 55(8):3595-613. PubMed ID: 22268494
[No Abstract] [Full Text] [Related]
18. Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors.
Xu B; Sun Y; Guo Y; Cao Y; Yu T
Bioorg Med Chem; 2009 Apr; 17(7):2767-74. PubMed ID: 19269831
[TBL] [Abstract][Full Text] [Related]
19. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
[TBL] [Abstract][Full Text] [Related]
20. Novel indole based NNRTIs with improved potency against wild type and resistant HIV.
Müller R; Mulani I; Basson AE; Pribut N; Hassam M; Morris L; van Otterlo WAL; Pelly SC
Bioorg Med Chem Lett; 2014 Sep; 24(18):4376-4380. PubMed ID: 25176191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
